EnteroMedics Announces Name Change to ReShape Lifesciences Inc. (NASDAQ: RSLS) PR Newswire ST. PAUL, Minn., Oct. 23, 2017 ST. PAUL, Minn., Oct. 23, 2017 /PRNewswire/ -- EnteroMedics Inc...
EnteroMedics Announces Presentations at ObesityWeek 2017 PR Newswire ST. PAUL, Minn., Oct. 16, 2017 ST. PAUL, Minn., Oct. 16, 2017 /PRNewswire/ -- EnteroMedics Inc. (NASDAQ:ETRM), a developer of...
EnteroMedics Announces New Employee Inducement Option Grants PR Newswire ST. PAUL, Minn., Oct. 12, 2017 ST. PAUL, Minn., Oct. 12, 2017 /PRNewswire/ -- EnteroMedics Inc. (NASDAQ:ETRM), a developer...
EnteroMedics Announces Acquisition Of ReShape Medical Acquisition Adds Approved, Revenue-Generating Balloon Technology for Obesity Conference Call and Webcast Today at 11am ET, 1-800-860-2442 for...
EnteroMedics to Present at the Ladenburg Thalmann 2017 Healthcare Conference PR Newswire ST. PAUL, Minn., Sept. 12, 2017 ST. PAUL, Minn., Sept. 12, 2017 /PRNewswire/ -- EnteroMedics Inc...
EnteroMedics Begins Post-Approval Study for the Treatment of Obesity with vBloc Therapy Study Designed to Further Demonstrate Long-Term Safety and Efficacy of vBloc for Weight Loss in Obese...
Study Concludes Vagal Nerve Blocking with EnteroMedics' vBloc Therapy is Cost-Effective vBloc Therapy Cost-Effectiveness Analysis Published in the American Journal of Managed Care PR Newswire ST...
EnteroMedics Announces First Veterans Choice Program vBloc® Implant at MedStar Health in Maryland PR Newswire ST. PAUL, Minn., Aug. 21, 2017 ST. PAUL, Minn., Aug. 21, 2017 /PRNewswire/...
EnteroMedics Announces Presentations Highlighting vBloc and Gastric Vest at IFSO Annual Conference PR Newswire ST. PAUL, Minn., Aug. 16, 2017 ST. PAUL, Minn., Aug. 16, 2017 /PRNewswire/...
EnteroMedics Announces Pricing of $20 Million Underwritten Public Offering PR Newswire ST. PAUL, Minn., Aug. 11, 2017 ST. PAUL, Minn., Aug. 11, 2017 /PRNewswire/ -- EnteroMedics Inc...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales